TELA Bio (TELA) Competitors $1.70 -0.15 (-8.11%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$1.70 0.00 (0.00%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. NNOX, STIM, NPCE, DRTS, NYXH, TCMD, SMTI, SKIN, BWAY, and CVRXShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Nano-X Imaging (NNOX), Neuronetics (STIM), NeuroPace (NPCE), Alpha Tau Medical (DRTS), Nyxoah (NYXH), Tactile Systems Technology (TCMD), Sanara MedTech (SMTI), Beauty Health (SKIN), Brainsway (BWAY), and CVRx (CVRX). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Nano-X Imaging Neuronetics NeuroPace Alpha Tau Medical Nyxoah Tactile Systems Technology Sanara MedTech Beauty Health Brainsway CVRx TELA Bio (NASDAQ:TELA) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment. Do institutionals and insiders have more ownership in TELA or NNOX? 94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 4.7% of TELA Bio shares are owned by company insiders. Comparatively, 7.7% of Nano-X Imaging shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media prefer TELA or NNOX? In the previous week, Nano-X Imaging had 1 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for Nano-X Imaging and 1 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.00 equaled Nano-X Imaging'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TELA Bio 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, TELA or NNOX? TELA Bio has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Nano-X Imaging has a beta of 1.95, suggesting that its stock price is 95% more volatile than the S&P 500. Is TELA or NNOX more profitable? TELA Bio has a net margin of -61.00% compared to Nano-X Imaging's net margin of -472.19%. Nano-X Imaging's return on equity of -30.92% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets TELA Bio-61.00% -402.45% -62.73% Nano-X Imaging -472.19%-30.92%-27.73% Do analysts rate TELA or NNOX? TELA Bio currently has a consensus target price of $7.25, indicating a potential upside of 326.47%. Nano-X Imaging has a consensus target price of $9.50, indicating a potential upside of 102.13%. Given TELA Bio's higher probable upside, research analysts clearly believe TELA Bio is more favorable than Nano-X Imaging.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Nano-X Imaging 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Which has preferable earnings & valuation, TELA or NNOX? TELA Bio has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTELA Bio$69.30M0.97-$37.84M-$1.41-1.21Nano-X Imaging$11.28M24.08-$53.52M-$0.90-5.22 SummaryNano-X Imaging beats TELA Bio on 9 of the 15 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$73.18M$3.01B$5.57B$9.47BDividend YieldN/A2.41%4.31%4.18%P/E Ratio-1.2116.5729.4123.99Price / Sales0.97316.60445.35187.89Price / CashN/A42.1735.8458.51Price / Book2.367.818.075.58Net Income-$37.84M-$54.52M$3.26B$265.35M7 Day PerformanceN/A0.41%0.45%-0.07%1 Month Performance-11.92%9.93%4.83%1.76%1 Year Performance-57.61%15.18%30.22%25.39% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.4893 of 5 stars$1.70-8.1%$7.25+326.5%-59.5%$73.18M$69.30M-1.21120Upcoming EarningsNNOXNano-X Imaging1.9576 of 5 stars$5.14-1.2%$9.50+84.8%-35.6%$300.45M$11.55M-5.71190News CoverageUpcoming EarningsSTIMNeuronetics1.1712 of 5 stars$4.52+0.7%$5.50+21.7%+135.6%$296.85M$74.89M-3.45180Trending NewsEarnings ReportAnalyst ForecastNPCENeuroPace3.1159 of 5 stars$8.74-2.7%$17.00+94.5%+23.5%$294.53M$79.91M-10.40170News CoverageUpcoming EarningsDRTSAlpha Tau Medical2.2382 of 5 stars$3.00-2.0%$8.00+166.7%+55.7%$259.55MN/A-6.5280News CoveragePositive NewsUpcoming EarningsNYXHNyxoah2.5987 of 5 stars$7.17-5.4%$14.50+102.2%-5.4%$258.18M$4.89M-3.37110Gap UpHigh Trading VolumeTCMDTactile Systems Technology3.0857 of 5 stars$10.52-0.3%$16.00+52.1%-8.5%$245.27M$292.98M15.941,037Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionSMTISanara MedTech1.6323 of 5 stars$25.03-2.0%$49.50+97.8%-11.5%$226.91M$86.67M-18.6860News CoveragePositive NewsUpcoming EarningsSKINBeauty Health1.6366 of 5 stars$1.76-1.7%$1.13-36.1%+21.4%$225.53M$334.30M-4.291,030Positive NewsBWAYBrainsway3.1106 of 5 stars$12.00+2.3%$14.25+18.8%+71.8%$221.67M$41.02M60.00120Positive NewsGap UpCVRXCVRx2.7302 of 5 stars$8.43+1.1%$14.50+72.0%-21.8%$217.45M$51.29M-3.87160News CoverageEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies Nano-X Imaging Competitors Neuronetics Competitors NeuroPace Competitors Alpha Tau Medical Competitors Nyxoah Competitors Tactile Systems Technology Competitors Sanara MedTech Competitors Beauty Health Competitors Brainsway Competitors CVRx Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
